CMS Open Payments · Program Year 2024
New World Medical,inc.
New World Medical,inc. reported $2,229,133.94 across General Payments, Research, and Ownership to 3,180 physicians and teaching hospitals across 3,294 transactions.
- $2.2M Top quartile payer
- All-tracks total
- 3,294 Top quartile volume
- Transactions
- 3,180 Top quartile reach
- Recipients
- −$95.3K
- General Payments vs PY2023
New World Medical,inc. reported $2,229,133.94 across all CMS Open Payments tracks (General + Research + Ownership) to 3,180 physicians and teaching hospitals in Program Year 2024 - ranking #426 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $334,148.45, averaging $700.99 per recipient.
How New World Medical,inc.'s $2.2M all-tracks total breaks down
New World Medical,inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
34/100
Total payments
F
31/100
Transaction volume
F
34/100
Physician reach
F
34/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer new-world-medical-inc New World Medical,inc.
$2.2M · #426/1,925 · 0.0% industry · PY2024
- TOT $2.2M
- RANK #426
- SHARE 0.0%
- TXN 3,294
- RCP 3,180
- CAT 3
- GEN $334.1K
- ΔGEN −$95.3K
- TOP1 6.2%
- PY 2024
Volume peers
Nearest volume peer: Orchard Therapeutics North America ($2.2M)
New World Medical,inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
New World Medical,inc.'s CMS-reported General Payments decreased by $95.3K (−22.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: NEW WORLD MEDICAL,INC.PY2023: NEW WORLD MEDICAL,INC.PY2024: NEW WORLD MEDICAL,INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $429,480.05
- PY2024
- $334,148.45
What the Data Shows for New World Medical,inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For New World Medical,inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $175.7K, accounting for 52.6% of this company's General Payments and 3,075 transactions.
General Payment Breakdown by Type
Across 3 types of general payments, New World Medical,inc.'s largest category was "Food and Beverage" at $175.7K - 52.6% of General Payments.
How New World Medical,inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $175.7K | 3,075 | 52.6% |
| Honoraria | $145.7K | 99 | 43.6% |
| Travel and Lodging | $12.8K | 6 | 3.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $59,313.20 (17.8%) of $334,148.45 in this company's General Payments records across 1,414 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for New World Medical,inc.
The five named recipients with the highest reported General Payments from this company
- 1
Jai G Parekh
$20,880.91 across 30 reported transactions
- 2
Analisa Arosemena
$15,697.25 across 21 reported transactions
- 3
Leon Walker Herndon
$10,315.91 across 5 reported transactions
- 4
Raju Sarwal
$7,169.46 across 16 reported transactions
- 5
Bac Nguyen
$5,249.67 across 29 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
New World Medical,inc. ranks #426 of 1,925 by total payments (top 22% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,666 of 1,838 by HHI (bottom 9% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Kairos Surgical Inc : $59.4K total payments, HHI 119
- Antares Pharma, Inc. : $489.5K total payments, HHI 119
- Corcept Therapeutics : $3.9M total payments, HHI 117
- Orthofix Medical, Inc. : $9.6M total payments, HHI 116
- Exact Sciences Corporation : $3.5M total payments, HHI 115
- BIOTRONIK NRO, Inc. : $814.5K total payments, HHI 114
- New World Medical,inc. (this company) : $334.1K total payments, HHI 114
- Sobi, Inc : $3.4M total payments, HHI 114
- Pyros Pharmaceuticals, Inc. : $9.7K total payments, HHI 114
- Oyster Point Pharma, Inc. : $1.1M total payments, HHI 113
- ImpactOrtho, Inc. : $52.7K total payments, HHI 113
- Glaukos Corporation : $3.6M total payments, HHI 112
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as New World Medical,inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about New World Medical,inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with New World Medical,inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Fujirebio Diagnostics, Incorporated
Smarter Devices, LLC
United Imaging Healthcare North America, Inc.
Ceribell, Inc.
Bluewind Medical
Put this to use
New World Medical,inc. ranks #426 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See where New World Medical,inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just New World Medical,inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.